Skip to content
HomeLatest newsHealth & wellnessPsyched about the eclipse? What you need to know to protect your eyes and watch it safely

Psyched about the eclipse? What you need to know to protect your eyes and watch it safely

On August 21, the U.S. will witness the first total eclipse of the sun in 40 years. In this video, get tips from a Johnson & Johnson expert on how to safeguard your eyes—and enjoy the one-of-a-kind celestial event.

On Monday, August 21, a total eclipse of the sun will be visible in parts of the continental U.S. for the first time in almost 40 years as the moon completely covers it—and observers in all states will experience at least a partial eclipse.

Because this phenomenon is so rare—the next total eclipse won’t occur in the U.S. until 2024—Americans across the country are clamoring to watch. And there’s no reason not to—as long as you do so safely: Even when blocked by the moon, the sun’s rays, both visible and invisible, can cause severe and permanent damage to the eyes.

So before you check out the eclipse, check out this video—featuring safe viewing tips from Johnson & Johnson Vision ultraviolet expert Cristina Schnider, O.D.


1775614113001-5544058705001-5544061612001-vs.jpg
Eclipse_v6

More from Johnson & Johnson

Meet the medical engineer behind the innovative heart pump that revolutionized cardiac health

Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 25 years since it entered the market, this groundbreaking device has helped more than 330,000 patients recover from heart injuries.

Reconnecting the meaning of these two simple words: Health&Care

Johnson & Johnson is restoring the true meaning of healthcare by developing advanced treatments and smarter and less invasive solutions for today’s most complex diseases.

What you need to know about Johnson & Johnson’s 2024 third quarter earnings

Check out this infographic breakdown of the company’s third quarter performance, with highlights from its Innovative Medicine and MedTech businesses.